Diabetes drugs tied to lower prostate cancer risk

NEW YORK (Reuters Health) - Drugs used to control diabetes may lower the risk of prostate cancer, investigators at the University of Tampere in Finland report.

“Recent studies have reported a decreased prostate cancer risk for diabetic men, although the evidence is controversial,” Dr. Teemu J. Murtola and colleagues note in the American Journal of Epidemiology. “It is currently unclear whether use of antidiabetic medication affects the association between diabetes and prostate cancer.”

To investigate, the investigators studied a group of men diagnosed prostate cancer and a group of “control” men without prostate cancer. The total cohort comprised 24,723 case-control pairs. The investigators also used a comprehensive prescription database to obtain information on medication use.

Oral diabetes drugs were used by 7.5 percent of men with prostate cancer and by 8.4 percent of controls. The prevalence of insulin use was 2.5 percent in the cases and 3.0 percent in the controls.

Men who had a history of taking any diabetes medication had a 16 percent lower risk of prostate cancer, Murtola’s team found.

The decreased risk was comparable for all antidiabetic drugs, including metformin, sulfonylureas and insulin.

The investigators found that the overall risk, as well as the risk of advanced prostate cancer, decreased with the amount and duration of medication use.

“The potential mechanism behind decreased prostate cancer risk for diabetic men is currently unclear,” Murtola’s group notes. “Most likely, the changes in endogenous hormone metabolism occurring in diabetes have an important role.”

SOURCE: American Journal of Epidemiology, October 15, 2008.


Related Posts:

NEW YORK (Reuters Health) - Men at higher-than-average risk of prostate cancer are more likely to seek regular screening if they are married or live with a significant other, a new study finds. Researchers found that among more than 2,400 men ages 40 to 79, those with a family history of prostate cancer were more likely

Full Post: Men who live alone fall short on prostate screening

NEW YORK (Reuters Health) - Data from the Women’s Health Initiative Observational Study show that higher than normal insulin levels are an independent risk factor for breast cancer. Study investigators, led by Dr. Marc J. Gunter at Albert Einstein College of Medicine in the Bronx, New York, examined the association between breast cancer and blood parameters

Full Post: High insulin levels may increase breast cancer risk

NEW YORK (Reuters Health) - A study of Vietnam War era veterans shows that exposure to Agent Orange is associated with more than a two-fold increased risk of prostate cancer, earlier disease onset, and prostate cancer with more aggressive features. “Consideration should be made to classify this group of individuals as ‘high risk’, just like men

Full Post: Agent Orange exposure linked to prostate cancer

By Joene Hendry NEW YORK (Reuters Health) - Use of a non-steroidal anti-inflammatory drug (NSAID) for over 5 years may lessen a person’s risk of developing cancer of the lower portion of the large bowel, study findings suggest. This risk reduction appears more robust among whites than among African Americans, Dr. Sangmi Kim, of the National Institute

Full Post: Pain pills may cut risk of bowel cancer: study

NEW YORK (Reuters Health) - Noscapine, a natural substance found in cough medicine, may prove useful in treating advanced prostate cancer, according to studies in mice. Researchers found that noscapine — a non-addictive derivative of opium — reduced tumor growth in mice by 60 percent and limited the spread of tumors by 65 percent without causing

Full Post: Cough medicine ingredient may treat prostate cancer

Site Navigation

Most Read



  • kinwrite.com@gmail.com